For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a ...

T-cells are the immune system's frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial ...

Immunotherapies – treatments that aim to make the body's natural immune system more effective – are becoming more widely used ...

Researchers have identified a target that may improve the response of CAR T-cell therapy, a treatment for patients with ...

T, has transformed treatment for blood cancers. The immunotherapy involves reprogramming a patient's own immune cells to ...

Researchers at UT Southwestern Medical Center led a study to develop a computational method that reveals how immune cells ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

Engineered cell products such as CAR T cells have demonstrated considerable therapeutic potential. Two studies in Science report new avenues to expand the applications of synthetic cell therapies – ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

SHANGHAI, June 22 (Reuters) - China's drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for ...

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

In 2024, two groundbreaking approvals from the US Food and Drug Administration for T cell-based therapies that target solid tumors were achieved. Lifileucel, a polyclonal tumor-infiltrating lymphocyte ...